Skip to content

MusclePharm Corporation: 10-Q filed 2014-10-31

What MusclePharm Corporation reported in its quarterly report filed 2014-10-31 (fiscal Q2 2014): 42 published measures, 113 facts as tagged in accession 0001144204-14-064325.

This filing

Form
10-Q (quarterly report)
Filed
2014-10-31
Fiscal period
fiscal Q2 2014
Accession
0001144204-14-064325 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All MusclePharm Corporation filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2014-06-3065,590,075USD
At 2013-12-3152,157,696USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2014-06-3028,839,495USD
At 2013-12-3132,423,160USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2014-06-3036,750,580USD
At 2013-12-3119,734,536USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-934,515USD91
2014-01-01 to 2014-06-301,801,719USD181
2013-04-01 to 2013-06-30-2,421,808USD91
2013-01-01 to 2013-06-30-9,783,789USD181

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

PeriodValueUnitDays
2014-01-01 to 2014-06-302,401,182USD181
2013-01-01 to 2013-06-30307,760USD181

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2014-06-30-80,025,698USD
At 2013-12-31-81,827,417USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2014-04-01 to 2014-06-3010,610,022shares91
2014-01-01 to 2014-06-3010,459,522shares181
2013-04-01 to 2013-06-307,226,849shares91
2013-01-01 to 2013-06-305,686,323shares181

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2014-04-01 to 2014-06-3010,610,022shares91
2014-01-01 to 2014-06-3011,863,882shares181
2013-04-01 to 2013-06-307,226,849shares91
2013-01-01 to 2013-06-305,686,323shares181

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-0.09USD/shares91
2014-01-01 to 2014-06-300.17USD/shares181
2013-04-01 to 2013-06-30-0.34USD/shares91
2013-01-01 to 2013-06-30-1.72USD/shares181

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-0.09USD/shares91
2014-01-01 to 2014-06-300.15USD/shares181
2013-04-01 to 2013-06-30-0.34USD/shares91
2013-01-01 to 2013-06-30-1.72USD/shares181

Income tax expense or benefit

Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.

PeriodValueUnitDays
2014-04-01 to 2014-06-3044,786USD91
2014-01-01 to 2014-06-3076,947USD181
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2014-06-306,221,261USD
At 2013-12-312,613,584USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2014-04-01 to 2014-06-302,117,332USD91
2014-01-01 to 2014-06-304,466,876USD181
2013-04-01 to 2013-06-3037,389USD91
2013-01-01 to 2013-06-3074,366USD181

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-863,328USD91
2014-01-01 to 2014-06-301,560,561USD181
2013-04-01 to 2013-06-30-2,740,931USD91
2013-01-01 to 2013-06-30-3,462,410USD181

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2014-06-3049,204,859USD
At 2013-12-3144,526,480USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2014-06-3028,473,117USD
At 2013-12-3132,368,521USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2014-06-3023,900,432USD
At 2013-12-3126,605,588USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2014-06-306,664,846USD

Net current accounts receivable

Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.

PeriodValueUnitDays
At 2014-06-3019,197,544USD
At 2013-12-3113,741,180USD

Common-stock repurchase payments

Cash paid to reacquire common stock during the period. This is not an authorization limit or a direct measure of the net change in share count.

PeriodValueUnitDays
2014-01-01 to 2014-06-300USD181
2013-01-01 to 2013-06-30103,537USD181

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2014-04-01 to 2014-06-3016,510,091USD91
2014-01-01 to 2014-06-3031,959,271USD181
2013-04-01 to 2013-06-3010,654,272USD91
2013-01-01 to 2013-06-3019,540,512USD181

Net inventory

Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.

PeriodValueUnitDays
At 2014-06-3019,769,356USD
At 2013-12-3115,772,368USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-3015,646,763USD91
2014-01-01 to 2014-06-3033,519,832USD181
2013-04-01 to 2013-06-307,913,341USD91
2013-01-01 to 2013-06-3016,078,102USD181

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2014-04-01 to 2014-06-302,356,940USD91
2014-01-01 to 2014-06-304,229,308USD181
2013-04-01 to 2013-06-301,918,665USD91
2013-01-01 to 2013-06-303,064,220USD181

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2014-04-01 to 2014-06-301,163,883USD91
2014-01-01 to 2014-06-302,260,829USD181
2013-04-01 to 2013-06-30169,231USD91
2013-01-01 to 2013-06-30259,361USD181

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2014-06-3010,612,912shares
At 2013-12-319,089,490shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2014-06-30118,259,128USD
At 2013-12-31103,064,901USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

PeriodValueUnitDays
At 2014-06-304,665USD
At 2013-12-31-14,042USD

Long-term debt

Long-term borrowings under this concept, which can include the current portion depending on presentation. It is not total liabilities and may exclude leases and other obligations.

PeriodValueUnitDays
At 2014-06-3045,600USD
At 2013-12-312,562,502USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

PeriodValueUnitDays
At 2014-06-308,216,809USD
At 2013-12-313,974,575USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2014-06-301,995,548USD
At 2013-12-311,360,991USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2014-06-306,732,532USD
At 2013-12-31155,165USD

Other noncurrent assets

Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-06-30179,632USD
At 2013-12-31144,229USD

Other noncurrent liabilities

Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.

PeriodValueUnitDays
At 2014-06-30366,378USD
At 2013-12-3154,639USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2014-06-304,527,085USD
At 2013-12-312,053,101USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-889,729USD91
2014-01-01 to 2014-06-301,878,666USD181
2013-04-01 to 2013-06-30-2,421,808USD91
2013-01-01 to 2013-06-30-9,783,789USD181

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2014-01-01 to 2014-06-30646,673USD181
2013-01-01 to 2013-06-30333,383USD181

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2014-04-01 to 2014-06-30293,113USD91
2014-01-01 to 2014-06-30578,295USD181
2013-04-01 to 2013-06-300USD91
2013-01-01 to 2013-06-300USD181

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2014-04-01 to 2014-06-30-26,401USD91
2014-01-01 to 2014-06-30318,105USD181
2013-04-01 to 2013-06-30319,123USD91
2013-01-01 to 2013-06-30-6,321,379USD181

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-304,790,307USD181
2013-01-01 to 2013-06-305,713,366USD181

Change in inventories

The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-303,155,989USD181
2013-01-01 to 2013-06-30170,254USD181

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2014-01-01 to 2014-06-30-2,664,980USD181
2013-01-01 to 2013-06-3080,187USD181

Inspect the source

Entity
MusclePharm Corporation / CIK 0001415684
Captured
SEC response SHA-256
468a04d5e93b916c24c9590128d034d873e433232d8fd2a3bf40cb8a957ad42c

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001415684.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))